Clinical Trial Update: Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization [Phase 3]

View source ↗

Summary

A Phase 3 trial updating reactogenicity, safety, and immunological efficacy of a live pentavalent rotavirus vaccine in childhood immunization has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infection

Drugs mentioned

• Live, Pentavalent Rotavirus Vaccine

Snippet

Sponsor: Limited Liability Company Pharm Aid | Conditions: Rotavirus Infection | Phase 3 | Status: COMPLETED